Pharmacological Therapies in Alzheimer's Disease

Research output: Chapter in Book/Report/Conference proceedingChapter

5 Scopus citations
Original languageEnglish (US)
Title of host publicationPrinciples and Practice of Geriatric Psychiatry
Subtitle of host publicationThird Edition
PublisherJohn Wiley and Sons
Number of pages8
ISBN (Print)9780470747230
StatePublished - Dec 2 2010


  • Alzheimer's disease (AD), progressive neurodegenerative disorder - deterioration in cognition and functioning, and neuropsychiatric co-morbidity
  • Cognition and function deterioration - and neuronal system degeneration
  • Common and less common side effects - of cholinesterase inhibitors and memantine
  • Donepezil and oral rivastigmine - in treatment of mild to moderate AD
  • Galantamine, FDA approved in 2001 - treatment of mild to moderately severe AD
  • Memantine trial, in patients - with moderate to severe AD
  • Neuropsychiatric effects of cholinesterase inhibitors and memantine
  • Pharmacological therapies - in Alzheimer's disease
  • Side effects of galantamine - identical to those of donepezil
  • Switching acetylcholinesterase inhibitors

ASJC Scopus subject areas

  • General Medicine

Cite this